Arrowhead Pharmaceuticals, Inc. (ARWR) SEC filings
ARWR SEC filings moved a median of -0.32% by the close. ARWR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ARWR overview →
59 measured ARWR SEC filing events.
Where these ARWR SEC filings landedvs 59 measured ARWR SEC filing reactions
| Middle 50% of ARWR SEC filing reactions | -2.30% to +3.59% |
|---|---|
| Median reaction (to close) | -0.32% |
| Measured reactions | 59 |
Point-in-time · zero look-ahead
Half of the 59 ARWR SEC filing events with a measured close landed between -2.30% and +3.59%; 49% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ARROWHEAD PHARMACEUTICAL For: Jun 30 | SEC filing · Form 10-Q | -1.20% | -0.66% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Aug 04 | SEC filing · Form 8-K | -1.20% | -0.66% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Jun 12 | SEC filing · Form 8-K | +0.40% | +5.87% | |
| Form 10-Q ARROWHEAD PHARMACEUTICAL For: Mar 31 | SEC filing · Form 10-Q | -4.65% | -4.98% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: May 07 | SEC filing · Form 8-K | -4.65% | -4.98% | |
| Form S-8 ARROWHEAD PHARMACEUTICAL | SEC filing · Form S-8 | -4.65% | -4.98% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Mar 19 | SEC filing · Form 8-K | +0.97% | -0.86% | |
| Form 10-Q ARROWHEAD PHARMACEUTICAL For: Dec 31 | SEC filing · Form 10-Q | +1.00% | -1.50% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Feb 05 | SEC filing · Form 8-K | +1.00% | -1.50% | |
| Form ARS ARROWHEAD PHARMACEUTICAL For: Jan 26 | SEC filing · Form ARS | +1.89% | +0.39% | |
| Form DEF 14A ARROWHEAD PHARMACEUTICAL For: Jan 26 | SEC filing · Form DEF | +1.89% | +0.39% | |
| Form DEFA14A ARROWHEAD PHARMACEUTICAL | SEC filing · Form DEFA14A | +1.89% | +0.39% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 12 | SEC filing · Form 8-K | -0.54% | -0.84% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 07 | SEC filing · Form 8-K | +0.76% | -1.44% | |
| Form 305B2 ARROWHEAD PHARMACEUTICAL | SEC filing · Form 305B2 | +0.76% | -1.44% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 06 | SEC filing · Form 8-K | +1.19% | -0.77% | |
| Form S-3ASR ARROWHEAD PHARMACEUTICAL | SEC filing · Form S-3ASR | +0.38% | +2.85% | |
| Form 10-K ARROWHEAD PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-K | +1.71% | +21.50% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Nov 25 | SEC filing · Form 8-K | +1.71% | +21.50% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Nov 18 | SEC filing · Form 8-K | -1.25% | -4.30% | |
| Form 10-K/A ARROWHEAD PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-K | +0.49% | +1.63% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Sep 11 | SEC filing · Form 8-K | -0.27% | -3.47% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Sep 10 | SEC filing · Form 8-K | +1.29% | +3.55% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Sep 02 | SEC filing · Form 8-K | +1.20% | +7.96% | |
| Form 10-Q ARROWHEAD PHARMACEUTICAL For: Jun 30 | SEC filing · Form 10-Q | -1.61% | +5.59% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Aug 07 | SEC filing · Form 8-K | -1.61% | +5.59% | |
| Form 10-Q ARROWHEAD PHARMACEUTICAL For: Mar 31 | SEC filing · Form 10-Q | -1.11% | -2.74% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: May 12 | SEC filing · Form 8-K | -1.11% | -2.74% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Apr 11 | SEC filing · Form 8-K | +0.51% | +0.16% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Mar 12 | SEC filing · Form 8-K | -0.13% | +3.00% | |
| Form 10-Q ARROWHEAD PHARMACEUTICAL For: Dec 31 | SEC filing · Form 10-Q | +2.47% | +3.62% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Feb 10 | SEC filing · Form 8-K | +2.47% | +3.62% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Feb 07 | SEC filing · Form 8-K | +4.18% | -1.56% | |
| Form DEFA14A ARROWHEAD PHARMACEUTICAL | SEC filing · Form DEFA14A | +4.18% | -1.56% | |
| Form ARS ARROWHEAD PHARMACEUTICAL For: Jan 28 | SEC filing · Form ARS | +0.55% | +0.35% | |
| Form DEF 14A ARROWHEAD PHARMACEUTICAL For: Jan 28 | SEC filing · Form DEF | +0.55% | +0.35% | |
| Form DEFA14A ARROWHEAD PHARMACEUTICAL | SEC filing · Form DEFA14A | +0.55% | +0.35% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Dec 11 | SEC filing · Form 8-K | -0.90% | -8.58% | |
| Form 10-K ARROWHEAD PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-K | -0.16% | +16.90% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Nov 26 | SEC filing · Form 8-K | -0.16% | +16.90% | |
| Form 10-Q ARROWHEAD PHARMACEUTICAL For: Jun 30 | SEC filing · Form 10-Q | -1.20% | -6.36% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Aug 08 | SEC filing · Form 8-K | -1.20% | -6.36% | |
| Form 10-Q ARROWHEAD PHARMACEUTICAL For: Mar 31 | SEC filing · Form 10-Q | -1.88% | -13.34% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: May 09 | SEC filing · Form 8-K | -1.88% | -13.34% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Mar 14 | SEC filing · Form 8-K | +0.62% | +2.40% | |
| Form 8-K/A ARROWHEAD PHARMACEUTICAL For: Feb 21 | SEC filing · Form 8-K | -1.25% | -0.49% | |
| Form S-8 ARROWHEAD PHARMACEUTICAL | SEC filing · Form S-8 | +1.59% | -6.96% | |
| Form DEFA14A ARROWHEAD PHARMACEUTICAL | SEC filing · Form DEFA14A | +0.87% | +9.75% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Feb 21 | SEC filing · Form 8-K | -1.26% | +3.18% | |
| Form 10-Q ARROWHEAD PHARMACEUTICAL For: Dec 31 | SEC filing · Form 10-Q | -3.02% | -0.32% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Feb 06 | SEC filing · Form 8-K | -3.02% | -0.32% | |
| Form ARS ARROWHEAD PHARMACEUTICAL For: Jan 26 | SEC filing · Form ARS | -1.72% | +5.46% | |
| Form DEF 14A ARROWHEAD PHARMACEUTICAL For: Jan 26 | SEC filing · Form DEF | -1.72% | +5.46% | |
| Form DEFA14A ARROWHEAD PHARMACEUTICAL | SEC filing · Form DEFA14A | -1.72% | +5.46% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 16 | SEC filing · Form 8-K | -0.92% | -1.86% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 02 | SEC filing · Form 8-K | +1.61% | +5.05% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Dec 05 | SEC filing · Form 8-K | +0.29% | +0.38% | |
| Form 10-K ARROWHEAD PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-K | -2.24% | -24.58% | |
| Form 8-K ARROWHEAD PHARMACEUTICAL For: Nov 29 | SEC filing · Form 8-K | -2.24% | -24.58% |
Keep exploring
More ARWR: earnings → · analyst actions → · ARWR overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | 392 | -0.45% | 45% |
| Rubius Therapeutics, Inc. (RUBY) | 392 | -0.32% | 45% |
| Axsome Therapeutics, Inc. (AXSM) | 391 | +0.05% | 52% |
| RA PHARMACEUTICALS (RARX) | 391 | -0.04% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.